Skip to main content

IFM Investors Pty Ltd

Position in NBIX — Neurocrine Biosciences Inc

CIK 1698246 MELBOURNE, C3

Position in NBIX

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$3,989,678
+$1,202,719 QoQ
Shares Held
23,672
+11.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#238
of 768 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

IFM Investors Pty Ltd holds $25,718,842 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (15.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
23,672 $3,989,678

All Filings in NBIX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,989,678 23,672
2026-03-31 $2,786,959 21,155
2025-12-31 $3,023,248 21,316
2025-09-30 $2,784,437 19,835
2025-06-30 $2,493,061 19,835
2024-12-31 $2,592,135 18,990
2024-09-30 $2,242,065 19,459
2024-06-30 $2,678,920 19,459
2024-03-31 $2,575,931 18,677
2023-12-31 $2,402,380 18,233
2023-09-30 $2,051,212 18,233
2023-06-30 $1,671,184 17,722
2023-03-31 $1,795,237 17,736
2022-12-31 $1,951,171 16,336
2022-09-30 $1,867,384 17,582
2022-06-30 $1,737,191 17,821
2021-12-31 $1,330,099 15,617
2021-09-30 $1,411,219 14,714
2021-06-30 $1,359,852 13,973
2021-03-31 $981,836 10,096
2020-12-31 $843,863 8,804
2020-09-30 $694,948 7,227
2020-06-30 $795,318 6,519
2020-03-31 $642,114 7,419